Dextera Surgical Inc  

(Public, NASDAQ:DXTR)   Watch this stock  
Find more results for NASDAQ:CRDC
2.34
-0.04 (-1.68%)
Jul 25 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.10 - 2.40
52 week 1.09 - 4.90
Open 2.10
Vol / Avg. 21,397.00/19,054.00
Mkt cap 20.82M
P/E     -
Div/yield     -
EPS -1.75
Shares 8.93M
Beta 0.02
Inst. own 45%
Aug 17, 2016
Cardica Inc at Wedbush PacGrow Healthcare Conference Add to calendar
May 5, 2016
Q1 2016 Cardica Inc Earnings Call - Webcast
May 5, 2016
Q1 2016 Cardica Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -160.50% -641.54%
Operating margin -154.61% -628.19%
EBITD margin - -586.22%
Return on average assets -58.24% -49.91%
Return on average equity - -137.77%
Employees 47 -
CDP Score - -

Address

900 Saginaw Dr
REDWOOD CITY, CA 94063-4753
United States - Map
+1-650-3649975 (Phone)
+1-650-3694024 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Dextera Surgical Inc, formerly Cardica, Inc., is focused on the commercialization and development of microcutter product line intended for use by surgeons. The Company is engaged in commercializing and developing MicroCutter XCHANGE 30 based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons. Its MicroCutter XCHANGE 30 is a cartridge based microcutter device with around five millimeter shaft diameter and around 30 millimeter staple line cleared for use in the United States for specific indications for use, and in the European Union for a range of indications for use. Its planned products include MicroCutter XCHANGE 45, MicroCutter XCHANGE 60 and MicroCutter FLEXCHANGE 30. The MicroCutter FLEXCHANGE name refers to the planned cartridge-based microcutter product with a flexible shaft that also includes its staple-on-a-strip technology.

Officers and directors

Julian Nikolchev President, Chief Executive Officer, Director
Age: 61
Bio & Compensation  - Reuters
Robert Y. Newell IV Chief Financial Officer, Vice President - Finance
Age: 67
Bio & Compensation  - Reuters
Thomas J. Palermo Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
Liam J. Burns Vice President - Sales and Marketing
Age: 50
Bio & Compensation  - Reuters
Gregory P. Watson Vice President of operation
Age: 60
Bio & Compensation  - Reuters
Michael A. Bates Director
Age: 57
Bio & Compensation  - Reuters
Gregory D. Casciaro Director
Age: 57
Bio & Compensation  - Reuters
R. Michael Kleine Director
Age: 62
Bio & Compensation  - Reuters
Samuel E. Navarro Director
Age: 59
Bio & Compensation  - Reuters
William H. Younger Jr. Independent Director
Age: 66
Bio & Compensation  - Reuters